Carbon disulfide
RTECS #
FF6650000
CAS #
Updated
March 2019
Molecular Weight
76.13
Molecular Formula
CS2
Synonyms
Carbon bisulfide
Carbon bisulphide
Carbon disulfide (ACGIH:OSHA)
Carbon disulphide
Carbone (sufure de) (French)
Carbonio (solfuro di) (Italian)
Dithiocarbonic anhydride
Kohlendisulfid (schwefelkohlenstoff) (German)
Koolstofdisulfide (zwavelkoolstof) (Dutch)
NCI-C04591
RCRA waste number P022
Schwefelkohlenstoff (German)
Solfuro di carbonio (Italian)
Sulphocarbonic anhydride
Weeviltox
Wegla dwusiarczek (Polish)
Carbon bisulphide
Carbon disulfide (ACGIH:OSHA)
Carbon disulphide
Carbone (sufure de) (French)
Carbonio (solfuro di) (Italian)
Dithiocarbonic anhydride
Kohlendisulfid (schwefelkohlenstoff) (German)
Koolstofdisulfide (zwavelkoolstof) (Dutch)
NCI-C04591
RCRA waste number P022
Schwefelkohlenstoff (German)
Solfuro di carbonio (Italian)
Sulphocarbonic anhydride
Weeviltox
Wegla dwusiarczek (Polish)
Mutation Data and Reference
| System Test | Route/Organism/Tissue | Dose | Reference |
|---|---|---|---|
| DNA Damage | intraperitoneal/mouse | 157.85 mg/kg | TXAPA9 273,381,2013 |
| mutation in microorganisms | /Salmonella typhimurium | 100 µL/plate (+enzymatic activation step) | NIOSH* 5AUG1977 |
| sister chromatid exchange | lymphocyte/human | 8 mg/L | TCMUD8 10,21,1990 |
| sister chromatid exchange | lymphocyte/human | 10200 µg/L | BCTKAG 14,115,1981 |
Reproductive Effects Data and References
| Route/Organism | Dose | Effect | Reference |
|---|---|---|---|
| inhalation/man | 40 mg/m3 (91W male) | Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) | MELAAD 60,566,1969 |
| inhalation/rat | 200 mg/m3/24H (1-21D pregnant) | Reproductive: Effects on fertility: Pre- implantation mortality (e.g., reduction in number of implants per female; total number of implants per corpora lutea) | KHZDAN 21,257,1978 |
| inhalation/rat | 10 mg/m3/8H (1-22D pregnant) | Reproductive: Specific developmental abnormalities: Eye, ear Reproductive: Effects on newborn: Viability index (e.g., # alive at day 4 per # born alive) | ATSUDG 4,252,1980 |
| inhalation/rat | 100 mg/m3/8H (1-22D pregnant) | Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain) | TOLED5 2,129,1978 |
| inhalation/rat | 100 mg/m3/8H (1-21D pregnant) | Reproductive: Effects on embryo or fetus: Fetal death Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue) Reproductive: Specific developmental abnormalities: Homeostasis | TJADAB 14,374,1976 |
| inhalation/rat | 30 µg/m3/8H (1-22D pregnant) | Reproductive: Effects on newborn: Behavioral | ATSUDG 4,252,1980 |
| inhalation/rat | 600 ppm/6H (50D male) | Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) Reproductive: Paternal effects: Prostate, seminal vesicle, Cowper's gland, accessory glands | TXAPA9 73,275,1984 |
| inhalation/mouse | 2000 mg/m3/2H (1-21D pregnant) | Reproductive: Effects on fertility: Pre- implantation mortality (e.g., reduction in number of implants per female; total number of implants per corpora lutea) Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth) | BEXBAN 68,1158,1969 |
| inhalation/mouse | 10 mg/m3/2H (3W prior to copulation) | Reproductive: Effects on fertility: Other measures of fertility | WDZAEK 4,139,1990 |
| intraperitoneal/mouse | 157.85 mg/kg (4D pregnant) | Reproductive: Maternal effects: Uterus, cervix, vagina Reproductive: Effects on fertility: Pre- implantation mortality (e.g., reduction in number of implants per female; total number of implants per corpora lutea) | TXAPA9 273,381,2013 |
| oral/rabbit | 350 mg/kg (6-19D pregnant) | Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | TOXID9 4,86,1984 |
| oral/rabbit | 2100 mg/kg (6-19D pregnant) | Reproductive: Other developmental abnormalities | TOXID9 4,86,1984 |
| oral/rabbit | 350 mg/kg (6-19D pregnant) | Reproductive: Effects on embryo or fetus: Fetal death Reproductive: Other developmental abnormalities | NTIS** #PB84-192350 |
| oral/rabbit | 2100 mg/kg (6-19D pregnant) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | NTIS** #PB84-192350 |
| oral/rat | 2000 mg/kg (6-15D pregnant) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | NTIS** #PB84-192343 |
Acute Toxicity Data and References
| Route/Organism | Dose | Effect | Reference |
|---|---|---|---|
| inhalation/human | Lowest published lethal concentration: 4000 ppm/30M | 29ZWAE -,118,1968 | |
| inhalation/human | Lowest published lethal concentration: 2000 ppm/5M | TABIA2 3,231,1933 | |
| inhalation/human | lowest published toxic concentration: 0.08 mg/m3 | Olfaction: Change in sensation of smell | VCVN5* -,208,1993 |
| inhalation/human | lowest published toxic concentration: 0.04 mg/m3 | Brain and Coverings: Recordings from specific areas of CNS Eye: Other eye effects | VCVN5* -,208,1993 |
| inhalation/human | Lowest published lethal concentration: 10000 mg/m3 | Eye: Other eye effects Behavioral: General anesthetic Behavioral: Ataxia | VCVN5* -,208,1993 |
| inhalation/human | lowest published toxic concentration: 1500 mg/m3/30M | Behavioral: Headache Gastrointestinal: Nausea or vomiting | VCVN5* -,209,1993 |
| inhalation/human | lowest published toxic concentration: 3600 mg/m3 | Peripheral Nerve and Sensation: Paresthesia Lung, Thorax, or Respiration: Cough | VCVN5* -,209,1993 |
| inhalation/mammal (species unspecified) | Lowest published lethal concentration: 2000 ppm/5M | AEPPAE 138,65,1928 | |
| inhalation/mouse | lethal concentration (50 percent kill): 10 gm/m3/2H | 85GMAT -,32,1982 | |
| inhalation/mouse | lethal concentration (50 percent kill): 10000 mg/m3 | VCVN5* -,207,1993 | |
| inhalation/rat | lethal concentration (50 percent kill): 25000 mg/m3 | VCVN5* -,207,1993 | |
| inhalation/rat | lethal concentration (50 percent kill): 1000 mg/m3 | Behavioral: Alteration of classical conditioning | VCVN5* -,207,1993 |
| inhalation/rat | Lowest published lethal concentration: 20000 mg/m3/1H | Behavioral: Excitement Behavioral: Coma Lung, Thorax, or Respiration: Dyspnea | VCVN5* -,207,1993 |
| inhalation/rat | lethal concentration (50 percent kill): 25 gm/m3/2H | 85GMAT -,32,1982 | |
| intraperitoneal/guinea pig | lowest published lethal dose: 400 mg/kg | Liver: Fatty liver degeneration | AIHAAP 35,21,1974 |
| intraperitoneal/rat | lowest published toxic dose: 7.6 mg/kg | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.) | TOXID9 66,126,2002 |
| oral/guinea pig | lethal dose (50 percent kill): 2125 mg/kg | VCVN5* -,207,1993 | |
| oral/mouse | lethal dose (50 percent kill): 2780 mg/kg | VCVN5* -,207,1993 | |
| oral/rabbit | lethal dose (50 percent kill): 2550 mg/kg | VCVN5* -,207,1993 | |
| oral/rat | lethal dose (50 percent kill): 1200 mg/kg | INHEAO 32,145,1994 | |
| unreported route/man | lowest published lethal dose: 186 mg/kg | 85DCAI 2,73,1970 |
Other Multiple Dose Data and References
| Route/Organism | Dose | Effect | Reference |
|---|---|---|---|
| inhalation/Dog | lowest published toxic concentration: 1250 mg/m3/8H/11W- intermittent | Brain and Coverings: Other degenerative changes Eye: Other eye effects Cardiac: EKG changes not diagnostic of above | JIHTAB 23,415,1941 |
| inhalation/human | lowest published toxic concentration: 9 mg/m3/3Y- intermittent | Gastrointestinal: Other changes Liver: Other changes | VCVN5* -,212,1989 |
| inhalation/human | lowest published toxic concentration: 10 mg/m3/10Y- intermittent | Brain and Coverings: Other degenerative changes Behavioral: Irritability Biochemical: Neurotransmitters or modulators (putative): Catecholamine levels in CNS | VCVN5* -,213,1989 |
| inhalation/human | lowest published toxic concentration: 15 mg/m3/10Y- intermittent | Cardiac: Cardiomyopathy including infarction Vascular: BP elevation not characterized in autonomic section | VCVN5* -,215,1989 |
| inhalation/man | lowest published toxic concentration: 30 mg/m3/10Y- intermittent | Endocrine: Change in LH Endocrine: Change in gonadotropins | JTEHD6 7,363,1981 |
| inhalation/monkey | lowest published toxic concentration: 1200 mg/m3/6H/20W- intermittent | Endocrine: Hyperglycemia Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) | ENVRAL 29,151,1982 |
| inhalation/monkey | lowest published toxic concentration: 160 ppm/6H/36D | Eye: Other eye effects | TOXID9 3,63,1983 |
| inhalation/mouse | lowest published toxic concentration: 0.018 mg/m3/3H/4W- intermittent | Behavioral: Somnolence (general depressed activity) Lung, Thorax, or Respiration: Respiratory depression | VCVN5* -,210,1989 |
| inhalation/mouse | lowest published toxic concentration: 0.018 mg/m3/3H/8W- intermittent | Nutritional and Gross Metabolic: Weight loss or decreased weight gain Nutritional and Gross Metabolic: Changes in: Cl | VCVN5* -,210,1989 |
| inhalation/mouse | lowest published toxic concentration: 114 mg/m3/8H/20W- intermittent | Gastrointestinal: Other changes Nutritional and Gross Metabolic: Weight loss or decreased weight gain Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | JIHTAB 18,733,1936 |
| inhalation/rabbit | lowest published toxic concentration: 10 mg/m3/2H/50W- intermittent | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase | VCVN5* -,211,1989 |
| inhalation/rat | lowest published toxic concentration: 1 mg/m3/24H/17W- continuous | Cardiac: Other changes Cardiac: Changes in heart weight Vascular: BP elevation not characterized in autonomic section | VCVN5* -,212,1989 |
| inhalation/rat | lowest published toxic concentration: 100 mg/m3/17W- intermittent | Cardiac: Changes in coronary arteries Vascular: Structural changes in vessels | TPKVAL 15,3,1979 |
| inhalation/rat | lowest published toxic concentration: 0.02 gm/m3/122D- intermittent | Brain and Coverings: Changes in circulation Peripheral Nerve and Sensation: Structural change in nerve or sheath Kidney, Ureter, and Bladder: Changes in blood vessels or in circulation of kidney | TPKVAL 4,117,1962 |
| inhalation/rat | lowest published toxic concentration: 700 mg/m3/14W- intermittent | Cardiac: Changes in heart weight Liver: Changes in liver weight Kidney, Ureter, and Bladder: Changes in kidney weight | JTEHF8 68,797,2005 |
| inhalation/rat | lowest published toxic concentration: 100 mg/m3/3H/6W- intermittent | Endocrine: Evidence of thyroid hyperfunction Endocrine: Adrenal cortex hypoplasia Endocrine: Effect on menstrual cycle | GTPRZ* 13,42,1969 |
| inhalation/rat | lowest published toxic concentration: 2300 mg/m3/2H/12D- intermittent | Peripheral Nerve and Sensation: Recording from peripheral motor nerve Gastrointestinal: Alteration in gastric secretion Gastrointestinal: Gastritis | VCVN5* -,209,1989 |
| inhalation/rat | lowest published toxic concentration: 10 mg/m3/24H/70D- continuous | Peripheral Nerve and Sensation: Recording from peripheral motor nerve Lung, Thorax, or Respiration: Emphysema Liver: Other changes | VCVN5* -,210,1989 |
| inhalation/rat | lowest published toxic concentration: 0.018 mg/m3/3H/4W- intermittent | Behavioral: Somnolence (general depressed activity) Lung, Thorax, or Respiration: Respiratory depression | VCVN5* -,210,1989 |
| inhalation/rat | lowest published toxic concentration: 0.018 mg/m3/3H/8W- intermittent | Nutritional and Gross Metabolic: Weight loss or decreased weight gain Nutritional and Gross Metabolic: Changes in: Cl | VCVN5* -,210,1989 |
| inhalation/rat | lowest published toxic concentration: 10 mg/m3/5H/13W- intermittent | Brain and Coverings: Other degenerative changes Endocrine: Other changes Biochemical: Neurotransmitters or modulators (putative): Dopamine at other sites | KHZDAN 25,339,1982 |
| inhalation/rat | lowest published toxic concentration: 2000 ppm/4H/2W- intermittent | Behavioral: Change in psychophysiological tests Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | AIHAAP 25,369,1964 |
| inhalation/rat | lowest published toxic concentration: 114 mg/m3/8H/20W- intermittent | Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis) Blood: Changes in spleen Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | JIHTAB 18,733,1936 |
| inhalation/rat | lowest published toxic concentration: 800 ppm/6H/12W- intermittent | Nutritional and Gross Metabolic: Weight loss or decreased weight gain Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes | TXAPA9 94,356,1988 |
| inhalation/rat | lowest published toxic concentration: 1500 mg/m3/5H/26W- intermittent | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes Biochemical: Metabolism (intermediary): Lipids including transport | TOLED5 10,139,1982 |
| inhalation/rat | lowest published toxic concentration: 800 mg/m3/5H/1Y- intermittent | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes | TOLED5 10,139,1982 |
| inhalation/rat | lowest published toxic concentration: 500 ppm/24H/25W- continuous | Peripheral Nerve and Sensation: Recording from afferent nerve Peripheral Nerve and Sensation: Recording from peripheral motor nerve Nutritional and Gross Metabolic: Weight loss or decreased weight gain | TOLED5 34,175,1986 |
| inhalation/rat | lowest published toxic concentration: 800 ppm/6H/15W- intermittent | Brain and Coverings: Recordings from specific areas of CNS Nutritional and Gross Metabolic: Weight loss or decreased weight gain | ARTODN 66,334,1992 |
| inhalation/woman | lowest published toxic concentration: 9.36 mg/m3/1Y- intermittent | Endocrine: Change in gonadotropins Endocrine: Effect on menstrual cycle Endocrine: Other changes | AAMST* 43,255,1997 |
| intraperitoneal/rat | lowest published toxic dose: 3 gm/kg/3D- intermittent | Spinal Cord: Other degenerative changes | TOXID9 8,245,1988 |
| intraperitoneal/rat | lowest published toxic dose: 6475 mg/kg/4W- intermittent | Brain and Coverings: Other degenerative changes Behavioral: Somnolence (general depressed activity) Behavioral: Excitement | WDZAEK 6,195,1992 |
| intraperitoneal/rat | lowest published toxic dose: 5600 mg/kg/35D- intermittent | Cardiac: Other changes Vascular: Structural changes in vessels Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) | WDZAEK 6,131,1992 |
| oral/mouse | lowest published toxic dose: 5512 mg/kg/5D- intermittent | Endocrine: Changes in thymus weight Nutritional and Gross Metabolic: Weight loss or decreased weight gain Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | JTEHD6 47,479,1996 |
| oral/rabbit | lowest published toxic dose: 25298 mg/kg/26W- intermittent | Cardiac: Changes in heart weight Endocrine: Hyperglycemia Immunological Including Allergic: Decrease in cellular immune response | GISAAA 31(1),13,1966 |
| oral/rabbit | lowest published toxic dose: 2100 mg/kg/14D- continuous | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | NTIS** #PB84-192350 |
| oral/rabbit | lowest published toxic dose: 1050 mg/kg/14D- continuous | Liver: Changes in liver weight Nutritional and Gross Metabolic: Weight loss or decreased weight gain | NTIS** #PB84-192350 |
| oral/rat | lowest published toxic dose: 4000 mg/kg/10D- continuous | Liver: Changes in liver weight Skin and Appendages: Other: Hair Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | NTIS** #PB84-192343 |
| oral/rat | lowest published toxic dose: 4000 mg/kg/10D- continuous | Peripheral Nerve and Sensation: Flaccid paralysis without anesthesia (usually neuromuscular blockage) Behavioral: Sleep | NTIS** #PB84-192343 |
| oral/rat | lowest published toxic dose: 2000 mg/kg/10D- continuous | Nutritional and Gross Metabolic: Weight loss or decreased weight gain | NTIS** #PB84-192343 |
| oral/rat | lowest published toxic dose: 18000 mg/kg/12W- intermittent | Peripheral Nerve and Sensation: Structural change in nerve or sheath Behavioral: Ataxia | ARTODN 83,587,2009 |
| oral/rat | lowest published toxic dose: 5055 mg/kg/4W- intermittent | Cardiac: Arrythmias (indlucing changes in conduction) Cardiac: Pulse rate decreased with fall in BP Nutritional and Gross Metabolic: Weight loss or decreased weight gain | BBIADT 49,121,1990 |
Reviews
| Organization | Standard | Reference |
|---|---|---|
| American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-time-weighted average 1 ppm (skin) | DTLVS* TLV/BEI,2013 |
| American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-Not classifiable as a human carcinogen | DTLVS* TLV/BEI,2013 |
| TOXICOLOGY REVIEW | AHJOA2 83,100,1972 | |
| TOXICOLOGY REVIEW | CRTXB2 2,365,1973 | |
| TOXICOLOGY REVIEW | AIHAAP 35,55,1974 | |
| TOXICOLOGY REVIEW | KHZDAN 16,208,1973 | |
| TOXICOLOGY REVIEW | CMTVAS 10(3),49,1973 | |
| TOXICOLOGY REVIEW | MUREAV 539,77,2003 | |
| TOXICOLOGY REVIEW | TOLED5 134,17,2002 | |
| TOXICOLOGY REVIEW | REPTED 25,192,2008 | |
| TOXICOLOGY REVIEW | HUTOX* -,577,1996 | |
| TOXICOLOGY REVIEW | TPHSDY 29,322,2008 | |
| TOXICOLOGY REVIEW | NEUCL* 23,377,2005 | |
| TOXICOLOGY REVIEW | NTAPM* -,239,1995 | |
| TOXICOLOGY REVIEW | NTAPM* -,265,1995 | |
| TOXICOLOGY REVIEW | NTAPM* -,629,1995 | |
| TOXICOLOGY REVIEW | NTAPM* -,671,1995 | |
| TOXICOLOGY REVIEW | NTAPM* -,689,1995 | |
| TOXICOLOGY REVIEW | NTAPM* -,711,1995 | |
| TOXICOLOGY REVIEW | NTAPM* -,727,1995 | |
| TOXICOLOGY REVIEW | NTAPM* -,747,1995 | |
| TOXICOLOGY REVIEW | MUREAV 759,27,2014 | |
| TOXICOLOGY REVIEW | TXCYAC 307,123,2013 | |
| TOXICOLOGY REVIEW | TXAPA9 266,345,2013 | |
| TOXICOLOGY REVIEW | RTOPDW 61,251,2011 |
Standards and Regulations
| Organization | Standard | Reference |
|---|---|---|
| Mine Safety and Health Administration (MSHA) STANDARD-air | time-weighted average 20 ppm (60 mg/m3) (skin) | DTLVS* 3,39,1971 |
| Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN check ACGIH TLV; | ||
| Occupational Exposure Limit IN SINGAPORE, VIETNAM check ACGIH TLV | ||
| Occupational Exposure Limit-ARAB Republic of Egypt | time-weighted average 10 ppm (30 mg/m3), Skin, JAN1993 | |
| Occupational Exposure Limit-AUSTRALIA | time-weighted average 10 ppm (31 mg/m3), JUL2008 | |
| Occupational Exposure Limit-AUSTRIA | MAK-TMW 10 ppm (30 mg/m3);KZW 40 ppm (120 mg/m3), skin, 2007 | |
| Occupational Exposure Limit-BELGIUM | time-weighted average 10 ppm (31 mg/m3), Skin, MAR2002 | |
| Occupational Exposure Limit-DENMARK | time-weighted average 5 ppm (15 mg/m3), skin, MAY2011 | |
| Occupational Exposure Limit-FINLAND | time-weighted average 5 ppm (15 mg/m3), skin, NOV2011 | |
| Occupational Exposure Limit-FRANCE | VME 10 ppm (30 mg/m3), VLE 25 ppm (75 mg/m3), FEB2006 | |
| Occupational Exposure Limit-GERMANY | MAK 5 ppm (16 mg/m3), skin, 2011 | |
| Occupational Exposure Limit-HUNGARY | time-weighted average 30 mg/m3, short term exposure limit 120 mg/m3, Skin, SEP2000 | |
| Occupational Exposure Limit-ICELAND | time-weighted average 5 ppm (16 mg/m3), skin, NOV2011 | |
| Occupational Exposure Limit-INDIA | time-weighted average 10 ppm (30 mg/m3), Skin, JAN1993 | |
| Occupational Exposure Limit-JAPAN | Occupational Exposure Limit 10 ppm (31 mg/m3), skin, MAY2012 | |
| Occupational Exposure Limit-KOREA | time-weighted average 10 ppm (30 mg/m3), 2006 | |
| Occupational Exposure Limit-MEXICO | time-weighted average 10 ppm (30 mg/m3), 2004 | |
| Occupational Exposure Limit-NEW ZEALAND | time-weighted average 10 ppm (31 mg/m3), skin, JAN2002 | |
| Occupational Exposure Limit-NORWAY | time-weighted average 5 ppm (15 mg/m3), JAN1999 | |
| Occupational Exposure Limit-PERU | time-weighted average 10 ppm (31 mg/m3), JUL2005 | |
| Occupational Exposure Limit-POLAND | MAC(time-weighted average) 18 mg/m3, MAC(short term exposure limit) 30 mg/m3, JAN1999 | |
| Occupational Exposure Limit-RUSSIA | time-weighted average 3 mg/m3, short term exposure limit 10 mg/m3, JUN2003 | |
| Occupational Exposure Limit-SWEDEN | time-weighted average 5 ppm (16 mg/m3);short term exposure limit 8 ppm (25 mg/m3), Skin, JUN2005 | |
| Occupational Exposure Limit-SWITZERLAND | MAK-week 5 ppm (15 mg/m3), KZG-week 10 ppm (30 mg/m3), skin, JAN2011 | |
| Occupational Exposure Limit-THAILAND | time-weighted average 20 ppm (60 mg/m3), short term exposure limit 30 ppm (90 mg/m3), JAN1993 | |
| Occupational Exposure Limit-THE NETHERLANDS | MAC-TGG 30 mg/m3, Skin, 2003 | |
| Occupational Exposure Limit-THE PHILIPPINES | time-weighted average 20 ppm (60 mg/m3), Skin, JAN1993 | |
| Occupational Exposure Limit-TURKEY | time-weighted average 10 ppm (65 mg/m3), Skin, JAN1993 | |
| Occupational Exposure Limit-UNITED KINGDOM | time-weighted average 10 ppm (32 mg/m3), skin, OCT2007 | |
| Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction) | 8H time-weighted average 20 ppm (60 mg/m3) (skin) | CFRGBR 29,1926.55,1994 |
| Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors) | 8H time-weighted average 20 ppm (60 mg/m3) (skin) | CFRGBR 41,50-204.50,1994 |
| Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (General Industry) | 8H time-weighted average 20 ppm;ceiling concentration 30 ppm;Pk 100 ppm/30M/8H | CFRGBR 29,1910.1000,1994 |
| Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards) | 8H time-weighted average 20 ppm (60 mg/m3) (skin) | CFRGBR 29,1915.1000,1993 |
NIOSH Documentation and Surveillance
| Organization | Standard | Reference |
|---|---|---|
| National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO CARBON DISULFIDE-air | 10H time-weighted average 1 ppm (Sk);short term exposure limit 10 ppm (Sk) | NIOSH* DHHS #92-100,1992 |
| National Occupational Exposure Survey 1983 | Hazard Code 17370; Number of Industries 20; Total Number of Facilities 751; Number of Occupations 44; Total Number of Employees Exposed 45760; Total Number of Female Employees Exposed 5834 | |
| National Occupational Hazard Survey 1974 | Hazard Code 17370; Number of Industries 24; Total Number of Facilities 1074; Number of Occupations 27; Total Number of Employees Exposed 24200 |
Status in Federal Agencies
Page last reviewed: November 16, 2018
Content
source: National Institute for Occupational Safety and Health